MedPath

Trial of tyrosine and its effect on working memory in healthy elderly and young people

Completed
Conditions
plasma tyrosine levels, working memory performance
Registration Number
NL-OMON23338
Lead Sponsor
Wageningen University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

• Aged 18-35 years or aged 60-75 years

• Normal and stable weight (BMI 18.5-25 kg/m2 and weight 50-95 kg)

Exclusion Criteria

• Thyroid problems, such as hyperthyroidism, hypothyroidism, thyroid cancer

• Using medication that can interfere with tyrosine’s action; monoamine oxidase inhibitors and other antidepressants, sympathomimetic amines, and opioids

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tyrosine plasma concentrations at T0, T90, T120, T150, T180, T210 and T240 at doses of 100 mg/kg body weight (elderly), 150/kg body weight mg (young and elderly) and 200 mg/kg body weight (elderly)
Secondary Outcome Measures
NameTimeMethod
Performance on the n-back task measured by accuracy (total number of hits) and reaction time (ms) on all doses
© Copyright 2025. All Rights Reserved by MedPath